• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/6

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

6 Cards in this Set

  • Front
  • Back
Symptoms suggestive of bacterial rhinosinusitis (rather than viral)? (7)
10-14 day duration
congestion, purulent rhinorrhea, postnasal drainage
unilateral facial or dental pain, pain on palpitation
headache
worse at night
periorbital edema
olfactory disturbances
Most common causative organisms of bacterial rhinosinusitis? (3)
Streptococcus pneumonia (20-43%)
Hemophilus Influenza (22-35%)
Moraxella Catarrhalis (2-10%)
When do you treat bacterial rhinosinusitis? With what? Duration?
Symptoms should be present at least 10 days before treatment with antibiotics is considered.

1st Line Therapy: Amoxicillin
2nd Line Therapy: (if fails amoxicillin) Augmentin 2g Q12 hours
Penicillin Allergic: 2nd or 3rd generation cephalosporin (1st gen does not cover H Flu; orals include cefuroxime, cefpodoxime,cefdinir, cefprozil)
If need to aviod B-lactams entirely: TMP/SMZ or azithromycin
Usual duration is 10-14 days; shorter course possible with azithromycin
Adjunctive therapies for bacterial rhinosinusitis? (4)
1) Intranasal glucocorticoids (may increase clinical cure rate)
2) Consider antihistamines (1st gen anticholinergics may acutally prevent mucous clearing and prolong symptoms)
3) Mucolytic therapy (guaifenesin may be ineffective, but is harmless)
4) Nasal saline irrigation (provides symptom relief, particularly with chronic sinusitis)
Most frequently encountered microbe in pharyngitis? Accounts for what % of cases?
Group A B-hemolytic strep

5-10% of cases
Resistance among what 4 organisms can be directly attributed to inappropriate use of antibiotics for URIs? Strategies for dealing with this resistance?
Streptococcus pneumoniae (up to 50% PCN resistant in some places)
Haemophilus influenzae (many are now B-lactamase producers)
Moraxella catarrhalis (up to 80% are now B-lactamase producers)
Streptococcus pyogenes (growing resistance to macrolides and clindamycin)

Appropriate usage; amoxicillin may not be used for life-threatening infections; amoxicillin must be used with a B-lactamase inhibitor if organism is a B-lactamase producer